
Wise’s Biolchim purchases 70% stake in Matécsa
Private-equity-backed Italian agrochemical business Biolchim has bolted on Hungarian potting soil and substrate manufacturer Matécsa.
Backed by the Italian buyout house Wise, Biolchim has acquired a 70% stake in the targeted company aiming to expand its business across eastern Europe. According to a source close to the matter, the Italian company supported the acquisition exclusively with balance sheet cash.
The transaction marks the third bolt-on acquisition for Bologna-based biostimulants producer Biolchim since the Wise's initial investment in 2013. In 2014, the company fully acquired Cifo and in 2015 took a controlling stake in West Coast Marine Bio Processing. The company posted €85m in revenues in 2016 and is understood to generate €14.2m EBITDA and have €15.5m net debt.
In January 2013, the GP backed the company's MBO for approximately €21m from San Paolo Imi and Assietta through its 2010-vintage vehicle Wisequity III, which held a final close on €180m in September 2011. Currently, the vehicle has six businesses in its portfolio: Alpitour World, Biolchim, Colcom Group, Primat, NTC-PH&T and Controls Group.
More recently, Wise closed the fundraising for its fourth vehicle, Wisequity IV, on its €215m hard-cap in March 2016. To date, the fund has closed three deals: Corob, KBC Fashion and Guarisco.
Company
Founded in 1988 and headquartered in Kecel, Matécsa produces potting soil, fertilisers and substrate through its brand Florimo. The company currently manages a peat mine, from which it extracts the main source for its products, and exports to Slovakia, Slovenia, Croatia, Bosnia Herzegovina, Romania and Bulgaria.
According to a statement, the company has 35 employees and generated €4m in revenues with €1.4m EBITDA.
People
Biolchim – Leonardo Valenti (CEO).
Matécsa – Zoltán Matécsa (founder, managing director).
Advisers
Acquirer – Simmons & Simmons (legal); Unicredit (M&A).
Company – Invescom Corporate Finance (corporate finance); Jalsovszky (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater